200 related articles for article (PubMed ID: 17644205)
41. Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination.
Salman HH; Irache JM; Gamazo C
Vaccine; 2009 Jul; 27(35):4784-90. PubMed ID: 19539576
[TBL] [Abstract][Full Text] [Related]
42. Immunological adjuvant effect of ginsenoside Rh4 from the roots of Panax notoginseng on specific antibody and cellular response to ovalbumin in mice.
Yang ZG; Ye YP; Sun HX
Chem Biodivers; 2007 Feb; 4(2):232-40. PubMed ID: 17311234
[TBL] [Abstract][Full Text] [Related]
43. Immune response to ovalbumin following bisphenol A administration in mice fed with a low level of dietary protein.
Alizadeh M; Ota F; Kassu A
J Microbiol Immunol Infect; 2007 Aug; 40(4):364-70. PubMed ID: 17712472
[TBL] [Abstract][Full Text] [Related]
44. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
Tafaghodi M; Sajadi Tabassi SA; Jaafari MR
Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972
[TBL] [Abstract][Full Text] [Related]
45. TNF superfamily member, TL1A, is a potential mucosal vaccine adjuvant.
Kayamuro H; Yoshioka Y; Abe Y; Katayama K; Yoshida T; Yamashita K; Yoshikawa T; Hiroi T; Itoh N; Kawai Y; Mayumi T; Kamada H; Tsunoda S; Tsutsumi Y
Biochem Biophys Res Commun; 2009 Jul; 384(3):296-300. PubMed ID: 19406102
[TBL] [Abstract][Full Text] [Related]
46. Characterisation of the oral adjuvant effect of lemnan, a pectic polysaccharide of Lemna minor L.
Popov SV; Golovchenko VV; Ovodova RG; Smirnov VV; Khramova DS; Popova GY; Ovodov YS
Vaccine; 2006 Jun; 24(26):5413-9. PubMed ID: 16725237
[TBL] [Abstract][Full Text] [Related]
47. Adjuvant effect of cationic liposomes and CpG depends on administration route.
Slütter B; Bal SM; Ding Z; Jiskoot W; Bouwstra JA
J Control Release; 2011 Sep; 154(2):123-30. PubMed ID: 21315779
[TBL] [Abstract][Full Text] [Related]
48. Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice.
Huang CF; Wu TC; Chu YH; Hwang KS; Wang CC; Peng HJ
Scand J Immunol; 2008 Nov; 68(5):502-10. PubMed ID: 18822109
[TBL] [Abstract][Full Text] [Related]
49. Biodegradable microparticles as controlled release antigen delivery systems.
O'Hagan DT; Rahman D; McGee JP; Jeffery H; Davies MC; Williams P; Davis SS; Challacombe SJ
Immunology; 1991 Jun; 73(2):239-42. PubMed ID: 2071168
[TBL] [Abstract][Full Text] [Related]
50. Haemolytic activities and adjuvant effect of Anemone raddeana saponins (ARS) on the immune responses to ovalbumin in mice.
Sun Y; Li M; Liu J
Int Immunopharmacol; 2008 Aug; 8(8):1095-102. PubMed ID: 18550013
[TBL] [Abstract][Full Text] [Related]
51. Butyl benzyl phthalate: effects on immune responses to ovalbumin in mice.
Dearman RJ; Betts CJ; Beresford L; Bailey L; Caddick HT; Kimber I
J Appl Toxicol; 2009 Mar; 29(2):118-25. PubMed ID: 18816477
[TBL] [Abstract][Full Text] [Related]
52. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
[TBL] [Abstract][Full Text] [Related]
53. Enhancement of ovalbumin-specific IgA responses via oral boosting with antigen co-administered with an aqueous Solanum torvum extract.
Israf DA; Lajis NH; Somchit MN; Sulaiman MR
Life Sci; 2004 Jun; 75(4):397-406. PubMed ID: 15147827
[TBL] [Abstract][Full Text] [Related]
54. In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery.
Chen F; Zhang ZR; Yuan F; Qin X; Wang M; Huang Y
Int J Pharm; 2008 Feb; 349(1-2):226-33. PubMed ID: 17825506
[TBL] [Abstract][Full Text] [Related]
55. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
[TBL] [Abstract][Full Text] [Related]
56. Contribution of the glycidic moieties to the haemolytic and adjuvant activity of platycodigenin-type saponins from the root of Platycodon grandiflorum.
Xie Y; Ye YP; Sun HX; Li D
Vaccine; 2008 Jun; 26(27-28):3452-60. PubMed ID: 18501482
[TBL] [Abstract][Full Text] [Related]
57. Platycodin D2 is a potential less hemolytic saponin adjuvant eliciting Th1 and Th2 immune responses.
Xie Y; Deng W; Sun H; Li D
Int Immunopharmacol; 2008 Aug; 8(8):1143-50. PubMed ID: 18550019
[TBL] [Abstract][Full Text] [Related]
58. Allergy adjuvant effect of particles from wood smoke and road traffic.
Samuelsen M; Nygaard UC; Løvik M
Toxicology; 2008 Apr; 246(2-3):124-31. PubMed ID: 18289765
[TBL] [Abstract][Full Text] [Related]
59. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
[TBL] [Abstract][Full Text] [Related]
60. The use of a mutant TNF-alpha as a vaccine adjuvant for the induction of mucosal immune responses.
Kayamuro H; Abe Y; Yoshioka Y; Katayama K; Nomura T; Yoshida T; Yamashita K; Yoshikawa T; Kawai Y; Mayumi T; Hiroi T; Itoh N; Nagano K; Kamada H; Tsunoda S; Tsutsumi Y
Biomaterials; 2009 Oct; 30(29):5869-76. PubMed ID: 19646748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
